Roxadustat reduces left ventricular mass index compared to rHuEPO in haemodialysis patients in a randomized controlled trial.
Tan W, Wang X, Sun Y, Wang X, He J, Zhong L, Jiang X, Sun Y, Tian E, Li Z, He L, Hao Y, Tang B, Hua W, Ma X, Yang J.
Tan W, et al. Among authors: tian e.
J Intern Med. 2024 May;295(5):620-633. doi: 10.1111/joim.13770. Epub 2024 Feb 11.
J Intern Med. 2024.
PMID: 38343089
Clinical Trial.